152 related articles for article (PubMed ID: 35790712)
1. Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.
Vassilakopoulos TP; Kravvariti E; Panitsas F; Angelopoulou MK; Liaskas A; Kontopidou FN; Yiakoumis X; Variami E; Dimopoulou MN; Siakantaris MP; Asimakopoulos JV; Arapaki M; Dimou M; Diamantopoulos P; Sachanas S; Chatzidimitriou C; Belia M; Konstantinou E; Boutsikas G; Petevi K; Kanellopoulos A; Kokoris S; Kyrtsonis MC; Viniou NA; Lakiotaki E; Tsourouflis G; Korkolopoulou P; Konstantopoulos K; Panayiotidis P; Pangalis GA
Blood Cancer J; 2022 Jul; 12(7):102. PubMed ID: 35790712
[No Abstract] [Full Text] [Related]
2. Treatment of lymphocyte-predominant Hodgkin lymphoma.
Engert A
Ann Oncol; 2008 Jun; 19 Suppl 4():iv45-6. PubMed ID: 18519402
[No Abstract] [Full Text] [Related]
3. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system relapse in Hodgkin lymphoma: Successful treatment without radiotherapy.
Das A; Chatterjee D; Mittal BR; Mukherjee KK; Radotra B; Bansal D
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27734575
[No Abstract] [Full Text] [Related]
5. Management of Relapsed and Refractory Hodgkin Lymphoma in 2018.
Rutherford SC; Leonard JP
JAMA Oncol; 2018 Aug; 4(8):1120-1121. PubMed ID: 30003234
[No Abstract] [Full Text] [Related]
6. Combination chemoradiotherapy in early Hodgkin lymphoma.
André MP
Hematol Oncol Clin North Am; 2014 Feb; 28(1):33-47. PubMed ID: 24287066
[TBL] [Abstract][Full Text] [Related]
7. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
Pinczés L; Miltényi Z; Illés Á
J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Bello CM; Bierman PJ; Blum KA; Dabaja B; Duron Y; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Maloney DG; Mansur D; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Poppe M; Pro B; Weiss L; Winter JN; Yahalom J;
J Natl Compr Canc Netw; 2011 Sep; 9(9):1020-58. PubMed ID: 21917626
[No Abstract] [Full Text] [Related]
9. Unusual presentation of classic Hodgkin lymphoma.
Lyapichev KA; You MJ
Blood; 2019 Jan; 133(5):502. PubMed ID: 30705049
[No Abstract] [Full Text] [Related]
10. Chemotherapy only in early stage Hodgkin lymphoma: more relapses but the same survival--what to do?
Connors JM
Curr Hematol Malig Rep; 2014 Sep; 9(3):217-21. PubMed ID: 24838494
[TBL] [Abstract][Full Text] [Related]
11. Classical Hodgkin lymphoma.
Brice P; de Kerviler E; Friedberg JW
Lancet; 2021 Oct; 398(10310):1518-1527. PubMed ID: 33493434
[TBL] [Abstract][Full Text] [Related]
12. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Wilder RB; Schlembach PJ; Jones D; Chronowski GM; Ha CS; Younes A; Hagemeister FB; Barista I; Cabanillas F; Cox JD
Cancer; 2002 Mar; 94(6):1731-8. PubMed ID: 11920535
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of Hodgkin lymphoma: chances of remission are good, treatment tolerance needs improvement].
Bischoff M
MMW Fortschr Med; 2011 Oct; 153(41):17. PubMed ID: 22046834
[No Abstract] [Full Text] [Related]
14. [Guideline for childhood Hodgkin's lymphoma].
;
Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):586-9. PubMed ID: 25224235
[No Abstract] [Full Text] [Related]
15. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Borchmann P; Plütschow A; Kobe C; Greil R; Meissner J; Topp MS; Ostermann H; Dierlamm J; Mohm J; Thiemer J; Sökler M; Kerkhoff A; Ahlborn M; Halbsguth TV; Martin S; Keller U; Balabanov S; Pabst T; Vogelhuber M; Hüttmann A; Wilhelm M; Zijlstra JM; Moccia A; Kuhnert G; Bröckelmann PJ; von Tresckow B; Fuchs M; Klimm B; Rosenwald A; Eich H; Baues C; Marnitz S; Hallek M; Diehl V; Dietlein M; Engert A
Lancet Oncol; 2021 Feb; 22(2):223-234. PubMed ID: 33539742
[TBL] [Abstract][Full Text] [Related]
16. Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
Körholz D; Mauz-Körholz C; Vordermark D; Kluge R; Dieckmann K
Klin Padiatr; 2014 Nov; 226(6-7):307-8. PubMed ID: 25431863
[No Abstract] [Full Text] [Related]
17. Does radiotherapy still have a place in Hodgkin lymphoma?
Yahalom J
Curr Hematol Malig Rep; 2009 Jul; 4(3):117-24. PubMed ID: 20425424
[TBL] [Abstract][Full Text] [Related]
18. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of radiotherapy for localized relapse in patients with Hodgkin's disease (IIB-IVB) who obtained a complete response with chemotherapy alone as initial treatment.
MacMillan CH; Bessell EM
Clin Oncol (R Coll Radiol); 1994; 6(3):147-50. PubMed ID: 8086347
[TBL] [Abstract][Full Text] [Related]
20. The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.
Hawkes EA; Wotherspoon A; Cunningham D
Leuk Lymphoma; 2012 Mar; 53(3):354-61. PubMed ID: 21812538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
